Skip to Content
Søg Menu
Vi dækker

ECTRIMS | European Committee for Treatment and Research in Multiple Sclerosis

ECTRIMS 2025

NMOSD Webinar – Clinical Insights and Recent Advances 

Join the webinar on advances in immunotherapy for NMOSD, MOGAD, and autoimmune encephalitis. Discover new data from immunopathological insights, and future treatment perspectives.

Gloria Dalla Costa

ECTRIMS 2025: Ultra-Processed Food Intake is Linked to Increased MS Disease Activity

/ Gloria Dalla Costa
ECTRIMS25 Play the Video

ECTRIMS 2024

Sahla El Mahdaoui

The effects of anti-CD20 therapy on TFH cells in relapsing-remitting MS

/ Sahla El Mahdaoui
ECTRIMS24MS Play the Video

ECTRIMS 2024: New Data Has the Potential to Paving the Way for More Personalised and Effective Treatment Plans

/ Jan Andreasen
ECTRIMS24MS

Top 4 mest sete MEDtalks fra ECTRIMS 2024

DMTs During Pregnancy in Women with MS Do Not Affect Relapse Rates in Postpartum Periods

/ Neurologi / Lene Von Kappelgaard

Poor Sleep Has a Deleterious Impact on Health-Related Quality of Life in People with MS

/ Neurologi / Martin Langeskov Christensen

New Biomarker and Comorbidity Insights in NMOSD and MOGAD

/ Neurologi / Nasrin Asgari

Nationwide Patient-Reported Outcome Portal for MS is Feasible and Provides Clinical Value

/ Neurologi / Rolf Pringler Holm
Back to top